These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1534550)

  • 21. Atrial natriuretic peptide behaviour and myocyte hypertrophic profile in combined pressure and volume-induced cardiac hypertrophy.
    Cavallero S; González GE; Puyó AM; Rosón MI; Pérez S; Morales C; Hertig CM; Gelpi RJ; Fernández BE
    J Hypertens; 2007 Sep; 25(9):1940-50. PubMed ID: 17762660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A possible physiological role of atrial natriuretic peptide in body fluid volume regulation.
    Hirata Y; Ishii M; Fukui K; Hayakawa H; Namba S; Dan Y; Ishimitsu T; Sugimoto T; Kimura K; Matsuoka H
    J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S63-8. PubMed ID: 2473354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.
    Mukoyama M; Nakao K; Hosoda K; Suga S; Saito Y; Ogawa Y; Shirakami G; Jougasaki M; Obata K; Yasue H
    J Clin Invest; 1991 Apr; 87(4):1402-12. PubMed ID: 1849149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
    Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
    Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial natriuretic peptide gene variants and circulating levels: implications in cardiovascular diseases.
    Rubattu S; Sciarretta S; Volpe M
    Clin Sci (Lond); 2014 Jul; 127(1):1-13. PubMed ID: 24611929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial natriuretic peptide and regulation of vascular function in hypertension and heart failure: implications for novel therapeutic strategies.
    Rubattu S; Calvieri C; Pagliaro B; Volpe M
    J Hypertens; 2013 Jun; 31(6):1061-72. PubMed ID: 23524910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The atrial natriuretic peptide: a changing view.
    Rubattu S; Volpe M
    J Hypertens; 2001 Nov; 19(11):1923-31. PubMed ID: 11677356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial natriuretic peptide. An overview of clinical pharmacology and pharmacokinetics.
    Tan AC; Russel FG; Thien T; Benraad TJ
    Clin Pharmacokinet; 1993 Jan; 24(1):28-45. PubMed ID: 8448971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial natriuretic peptide (ANP) as a neuropeptide: interaction with angiotensin II on volume control and renal sodium handling.
    Unger T; Badoer E; Gareis C; Girchev R; Kotrba M; Qadri F; Rettig R; Rohmeiss P
    Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):83S-88S. PubMed ID: 2148493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Midregional pro-atrial natriuretic peptide, an important member of the natriuretic peptide family: potential role in diagnosis and prognosis of cardiovascular disease.
    Idzikowska K; Zielińska M
    J Int Med Res; 2018 Aug; 46(8):3017-3029. PubMed ID: 30027789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ANP--a cardiac hormone and a putative central neurotransmitter.
    Hedner T; Hedner J; Andersson O; Persson B; Pettersson A
    Eur Heart J; 1987 May; 8 Suppl B():87-98. PubMed ID: 2956108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial natriuretic peptide in cardiovascular biology and disease (NPPA).
    Song W; Wang H; Wu Q
    Gene; 2015 Sep; 569(1):1-6. PubMed ID: 26074089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current indications of plasma atrial natriuretic peptide measurements in human diseases.
    Dussaule JC; Ardaillou R
    Horm Res; 1990; 34(3-4):133-7. PubMed ID: 2151773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms for the release of atrial natriuretic peptide.
    Rankin AJ
    Can J Physiol Pharmacol; 1987 Aug; 65(8):1673-9. PubMed ID: 2961420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological significance of atrial natriuretic peptide in the kidney.
    Awazu M; Ichikawa I
    Nephron; 1993; 63(1):1-14. PubMed ID: 8446232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Atrial natriuretic peptide (ANP)--its role under physiologic conditions and certain clinical conditions].
    Surdacki A; Dubiel JS
    Pol Arch Med Wewn; 1993 Dec; 90(6):391-7. PubMed ID: 8146041
    [No Abstract]   [Full Text] [Related]  

  • 37. Atrial natriuretic peptide and the baroreflex control of circulation.
    Volpe M
    Am J Hypertens; 1992 Jul; 5(7):488-93. PubMed ID: 1386221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial natriuretic peptide.
    McIntyre RW; Schwinn DA
    J Cardiothorac Anesth; 1989 Feb; 3(1):91-8. PubMed ID: 2535291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial natriuretic peptide: an old hormone or a new cytokine?
    De Vito P
    Peptides; 2014 Aug; 58():108-16. PubMed ID: 24973596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemistry of atrial natriuretic peptide in brain infarction.
    Nogami M; Shiga J; Takatsu A; Endo N; Ishiyama I
    Histochem J; 2001 Feb; 33(2):87-90. PubMed ID: 11432644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.